U2AF2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.314800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.598800E-01
Normal-vs-Stage2
8.259600E-01
Normal-vs-Stage3
4.253600E-01
Normal-vs-Stage4
5.589000E-01
Stage1-vs-Stage2
8.781800E-01
Stage1-vs-Stage3
3.159200E-01
Stage1-vs-Stage4
1.464650E-01
Stage2-vs-Stage3
1.968030E-01
Stage2-vs-Stage4
2.731200E-01
Stage3-vs-Stage4
1.029600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.563400E-01
Normal-vs-AfricanAmerican
8.896800E-01
Normal-vs-Asian
5.628200E-01
Caucasian-vs-AfricanAmerican
9.899800E-01
Caucasian-vs-Asian
4.297200E-01
AfricanAmerican-vs-Asian
5.662600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.424800E-01
Normal-vs-Female
8.286600E-01
Male-vs-Female
8.887200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.129600E-01
Normal-vs-Age(41-60Yrs)
8.250200E-01
Normal-vs-Age(61-80Yrs)
6.970600E-01
Normal-vs-Age(81-100Yrs)
6.781000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.883800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.330600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.451200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.959600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.338400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.998200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.511400E-01
Normal-vs-Daily Drinker
9.506600E-01
Normal-vs-Weekly Drinker
9.972400E-01
Normal-vs-Occasional Drinker
6.527400E-01
Normal-vs-Social Drinker
8.505200E-01
Non Drinker-vs-Daily Drinker
1.125020E-01
Non Drinker-vs-Weekly Drinker
3.513000E-01
Non Drinker-vs-Occasional Drinker
1.303510E-02
Non Drinker-vs-Social Drinker
2.045200E-01
Daily Drinker-vs-Weekly Drinker
9.145200E-01
Daily Drinker-vs-Occasional Drinker
5.569000E-01
Daily Drinker-vs-Social Drinker
5.001000E-01
Weekly Drinker-vs-Occasional Drinker
5.946000E-01
Weekly Drinker-vs-Social Drinker
7.375800E-01
Occasional Drinker-vs-Social Drinker
1.117160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.658200E-01
Normal-vs-Grade 2
8.399200E-01
Normal-vs-Grade 3
8.616800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.272000E-01
Grade 1-vs-Grade 3
9.281200E-01
Grade 1-vs-Grade 4
8.658200E-01
Grade 2-vs-Grade 3
3.193200E-01
Grade 2-vs-Grade 4
8.399200E-01
Grade 3-vs-Grade 4
8.616800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.808200E-01
Normal-vs-NonDiabetic
9.404200E-01
Diabetic-vs-NonDiabetic
1.451610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.638400E-01
Normal-vs-NoPancreatitis
8.380000E-01
Pancreatitis-vs-NoPancreatitis
5.948400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.512600E-01
Normal-vs-N1
8.269400E-01
N0-vs-N1
8.134800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.580000E-01
Normal-vs-TP53-NonMutant
6.141200E-01
TP53-Mutant-vs-TP53-NonMutant
6.236500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
